logo
logo
Sign in

Antacids Market 2025 Report by Emerging Trends, Application Scope, Size, Status

avatar
Rahul Sharma
Antacids Market 2025 Report by Emerging Trends, Application Scope, Size, Status

The scope of the global Antacids Market was appreciated at US$ 5.83 billion in 2017. The range is projected to touch US$ 7.91 billion by 2025, growing at a CAGR of 3.9% for the duration of the forecast. This could be due to increase in geriatric population encountering GERD (Gastroesophageal reflux disease), poor eating habits causing acidity, and the ill-effects of anti-inflammatory, non-steroidal drugs.

 

Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/antacids-market/request-sample

 

Market Synopsis of Antacids Market:

 

It’s a known fact that amongst the elderly populace, there is a recurrence of acidic complications. This comes across as a challenge for gastroenterologist as well as the primary care provider. Plus, these patients do suffer from disorders like erosive esophagitis, esophageal cancer, and Barrett esophagus. The treatment herein needs an amalgamation of therapies. This is where antacids come into picture.

 

Besides, growth in e-Commerce is expected to drive demand for antacids via online retailing channels in the subsequent years. In other words, growing popularity on the part of e-Commerce coupled with increase in online medicine providers is expected to bolster the market. At the same time, restraints do exist in the form of intake by young children. “Gut” journal states that young children displayed obesity symptoms on intake of antacids. As far as infants are concerned, antacids are a strict “no-no”. Even during pregnancy antacids should be avoided as chances of pre-mature birth can’t be ruled out.

 

The antacids market is segmented on the basis of drug class, type of formulation, distribution channel, and geography. By drug class, the segmentation spans proton pump inhibitors, H2 antagonist (interventional/surgical simulators), and acid neutralizers. By type of formulation, the antacids industry comprises tablet, liquid, and powder. By distribution channel, it consists of retail pharmacies, hospital pharmacies, and the other distribution channels. By geography, the antacid market is segmented into North America, LATAM, Asia Pacific, Europe, and MEA.

 

The players contributing to the antacids market include Bayer AG, AstraZeneca PLC, Sanofi S.A., Reckitt Benckiser Group PLC, Procter & Gamble, Pfizer Inc., Johnson & Johnson, and Dr. Reddy’s Laboratories Ltd.

 

View Full Table of Contents of This Report @ https://www.millioninsights.com/industry-reports/antacids-market

 

Table of Contents:-

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Antacids: Market Variables, Trends & Scope              

Chapter 4 Antacids: Product Estimates & Trend Analysis

Chapter 5 Antacids: Application Estimates & Trend Analysis

Chapter 6 Antacids: End-use Estimates & Trend Analysis

Chapter 7 Antacids: Industrial End-use Estimates & Trend Analysis

Chapter 8 Antacids: Regional Estimates & Trend Analysis

Chapter 9 Competitive Landscape

Chapter 10 Antacids: Manufacturers Company Profiles

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

collect
0
avatar
Rahul Sharma
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more